Clinical Trial Protocol Description:
The purpose of this study is to test the Epione robot, developed by French company Precision IO Group, to assist interventional radiologists in percutaneous treatments, which are minimally invasive procedures done through the skin. Epione is a device already approved by the U.S. Food and Drug Administration (FDA) for abdominal minimally invasive procedures. This study aims to confirm the performance and safety of the Epione device in assisting percutaneous procedures on musculoskeletal structures of the pelvis and the spine. Your participation is expected to last 30 days following your procedure.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are 22 years of age or older.
- Are scheduled to have a percutaneous procedure to treat a bone tumor or a fracture in the pelvis or spine under general anesthesia.
You will be excluded from the study if any of the following criteria apply to you:
- Have contraindication to undergo general anesthesia.
- Require image-guided percutaneous procedure on areas other than the pelvis or spine.
- Have a bleeding disorder.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
Contact Information